Topics to be Discussed:

• Gain insight into the legal and regulatory landscape of off-label information dissemination with an overview of the FDA, OIG, US Attorney’s Office and individual state rules
• Review the difference between scientific exchange of information versus promotion
• Minimize risk in the activities of sales representatives, medical science liaisons, marketers and others who engage in medical communications
• Understand the challenges of non-traditional media and the corresponding rules of promotion
• Analyze case studies of compliant and noncompliant off-label information communication
• Examine the situations in which off-label information sharing is acceptable and how to engage most effectively